arrow
Back
S

Sibylle Loibl

gbg forschungs gmbh

131H-index
1.5KPaper Count
9.5WCitation Count
Published Papers 429
Publication Date
First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study☆
err2026-06-11
err0
errOAAI
errM. Schmidt; M. Thill; J. Rey; B. Rautenberg; V. Bjelic-Radisic; T. Decker; J. Rom; M. Kögel; K. Lübbe; A. Nacke; S. Seiler; M. Just; V. Müller; R. Buss-Steidle; J. Terhaag; C. Mundhenke; C. Denkert; J. Holtschmidt; S. Loibl
errShare
errSave
Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib–fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer
err2026-05-27
err0
errOAAI
errS.-A. Im; K. Kalinsky; K.L. Jhaveri; S. Loibl; N. Turner; C. Saura; P. Schmid; S. Loi; E. Hamilton; N. Karadurmus; S. Wang; A.A. Awan; E.M. Ciruelos; C.-F. Chung; E. Thanopoulou; N. Shankar; S. Lim; Y. Jin; C. Song; D. Juric
errShare
errSave
Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial
err2026-05-09
err0
errOAAI
errP. Filis; X. Liu; A. Matikas; M. Untch; G.G. Steger; H. Johansson; M. Hellström; M. Gnant; S. Loibl; Y. Brandberg; J. Bergh; T. Foukakis
errShare
errSave
Preoperative Immunotherapy in Oncology
err2026-01-23
err1
PREAI
errHofheinz, Ralf-Dieter; Lorenzen, Sylvie; Sebastian, Martin; Bolukbas, Servet; Fichtner-Feigl, Stefan; Loibl, Sibylle
errShare
errSave
Molecular testing for therapeutic purposes in breast cancer - assistance for clinical practice
err2025-11-01
err0
PREAI
errHoltschmidt, Johannes; Rhiem, Kerstin; Denkert, Carsten; Decker, Thomas; Loibl, Sibylle
errShare
errSave
Tailoring Treatment to Cancer Risk and Patient Preference: The 2025 St Gallen International Breast Cancer Consensus Statement on Individualizing Therapy for Patients With Early Breast Cancer
err2025-10-08
err0
errOAAI
errH.J. Burstein; G. Curigliano; M. Gnant; S. Loibl; M.M. Regan; S. Loi; C. Denkert; P. Poortmans; D. Cameron; B. Thurlimann; W.P. Weber
errShare
errSave
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025
err2025-09-17
err0
PREAI
errToralf Reimer; Thorsten Kuehn; Volkmar Mueller; Nina Ditsch; Tanja Fehm; Ute-Susann Albert; Rupert Bartsch; Ingo Bauerfeind; Vesna Bjelic-Radisic; Jens-Uwe Blohmer; Wilfried Budach; Peter Dall; Eva Maria Fallenberg; Peter A. Fasching; Michael Friedrich; Bernd Gerber; Oleg Gluz; Nadia Harbeck; Andreas Hartkopf; Joerg Heil; Juliane Hoerner-Rieber; Jens Huober; Wolfgang Janni; Hans-Heinrich Kreipe; David Krug; Sherko Kuemmel; Sibylle Loibl; Diana Lueftner; Michael Patrick Lux; Nicolai Maass; Christoph Mundhenke; Tjoung-Won Park-Simon; Mattea Reinisch; Kerstin Rhiem; Achim Rody; Marcus Schmidt; Andreas Schneeweiss; Florian Schuetz; Hans-Peter Sinn; Christine Solbach; Erich-Franz Solomayer; Elmar Stickeler; Christoph Thomssen; Michael Untch; Marion van Mackelenbergh; Isabell Witzel; Achim Woeckel; Rachel Wuerstlein; Maggie Banys-Paluchowski; Marc Thill
errShare
errSave
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study
err2025-06-01
err0
errOAAI
errL. García-Estévez; A. Bardia; H.S. Rugo; L.A. Carey; V.C. Diéras; S. Loibl; M. Piccart; L. Gianni; K. Kalinsky; J. O’Shaughnessy; S.A. Hurvitz; E. Harting; T. Valdez; S. Phan; C. Lai; J. Cortés
errShare
errSave
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC
errBREAST
IF7.9
err2025-06-01
err0
errOAAI
errLaakmann, Elena; Schmidt, Marcus; Luebbe, Kristina; Agostinetto, Elisa; van Ramshorst, Mette; Decker, Thomas; Malter, Wolfram; Schettini, Francesco; Sousa, Mario Fontes; Denkert, Carsten; Neunhoeffer, Tanja; Matos, Leonor; Linn, Sabine; Thill, Marc; Weide, Rudolf; Fitzpatrick, Amanda; Batista, Marta Vaz; Mundhenke, Christoph; Park-Simon, Tjoung-Won; Le Du, Fanny; Riecke, Kerstin; Fehm, Tanja; Witzel, Isabel; Rey, Julia; Nekljudova, Valentina; Loibl, Sibylle; Mueller, Volkmar
errShare
errSave
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification
err2025-05-14
err0
errOAAI
errGalas, Kristin; Gleitsmann, Moritz; Rey, Julia; Solbach, Christine; Witzel, Isabell; Karn, Thomas; Schmatloch, Sabine; Schem, Christian; Schneeweis, Andreas; Sinn, Bruno; Fehm, Tanja; Denkert, Carsten; Fasching, Peter; Litmeyer, Anne-Sophie; Marme, Frederik; Jank, Paul; Mueller, Volkmar; Seiler, Sabine; Stickeler, Elmar; Ortmann, Olaf; van Mackelenbergh, Marion; Nekljudova, Valentina; Holtschmidt, Johannes; Loibl, Sibylle
errShare
errSave
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial
err2025-02-01
err1
PREAI
errMatikas, Alexios; Papakonstantinou, Andri; Loibl, Sibylle; Steger, Guenther G.; Untch, Michael; Johansson, Hemming; Hellstrom, Mats; Greil, Richard; Moebus, Volker; Gnant, Michael; Bergh, Jonas
errShare
errSave
Chemotherapy in older patients with early breast cancer
errBREAST
IF7.9
err2024-12-01
err1
PREAI
errSchmidt, Marcus; Loibl, Sibylle
errShare
errSave
Summary of quality of life in the ASCENT phase 3 clinical trial for people with metastatic triple-negative breast cancer : A plain language summary
err2024-09-26
err0
errOAAI
errLoibl, Sibylle; Loirat, Delphine; Tolaney, Sara M.; Punie, Kevin; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Shah, Anuj; Phan, See; Shi, Ling; Spears, Patricia A.; Piccart, Martine J.
errShare
errSave
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer
err2024-09-24
err0
errOAAI
errSinn, Bruno Valentin; Sychra, Katharina; Untch, Michael; Karn, Thomas; van Mackelenbergh, Marion; Huober, Jens; Schmitt, Wolfgang; Marme, Frederik; Schem, Christian; Solbach, Christine; Stickeler, Elmar; Tesch, Hans; Fasching, Peter A.; Schneeweiss, Andreas; Mueller, Volkmar; Holtschmidt, Johannes; Nekljudova, Valentina; Loibl, Sibylle; Denkert, Carsten
errShare
errSave
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer
err2024-09-16
err2
errOAAI
errTurner, Nicholas C.; Oliveira, Mafalda; Howell, Sacha J.; Dalenc, Florence; Cortes, Javier; Gomez, Henry L.; Hu, Xichun; Jhaveri, Komal; Krivorotko, Petr; Loibl, Sibylle; Murillo, Serafin Morales; Park, Yeon Hee; Sohn, Joo-Hyuk; Toi, Masakazu; Tokunaga, Eriko; Yousef, Samih; Zhukova, Lyudmila; de Bruin, Elza; Grinsted, Lynda; Schiavon, Gaia; Foxley, Andrew; Rugo, Hope S.
errShare
errSave
Overall survival and updated invasive disease free survival results from the Penelope-B trial investigating palbociclib vs placebo for patients with high-risk HR+/HER2-breast cancer and residual disease after NACT
err2024-09-01
err0
PREAI
errLoibl, S.; Martin Jimenez, M.; Bonnefoi, H.; Untch, M.; Kim, S-B.; Bear, H. D.; McCarthy, N. J.; Gelmon, K. A.; Garcia Saenz, J. A.; Kelly, C. M.; Reimer, T.; Zhang, Z.; Toi, M.; Rugo, H. S.; Gnant, M. I.; Makris, A.; Debiasi, M.; Hirmas, N.; Nekljudova, V.; Marme, F.
errShare
errSave
Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?
err2024-09-01
err2
errOAAI
errValenza, C.; Trapani, D.; Bidard, F. -c.; Gligorov, J.; Cortes, J.; Turner, N.; Dalenc, F.; Penault-Llorca, F.; Freyer, G.; Arnedos, M.; Villanueva, C.; Loibl, S.; Pistilli, B.; Curigliano, G.
errShare
errSave
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer
err2024-07-30
err0
errOAAI
errMoebus, Volker; Lueck, Hans-Joachim; Ladda, Ekkehart; Klare, Peter; Engels, Knut; Schmidt, Marcus; Schneeweiss, Andreas; Grischke, Eva-Maria; Wachsmann, Grischa; Forstbauer, Helmut; Untch, Michael; Marme, Frederik; Blohmer, Jens-Uwe; Jackisch, Christian; Huober, Jens; Stickeler, Elmar; Reinisch, Mattea; Link, Theresa; Sinn, Bruno; Janni, Wolfgang; Denkert, Carsten; Seiler, Sabine; Solbach, Christine; Schmatloch, Sabine; Rey, Julia; Loibl, Sibylle
errShare
errSave
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer (vol 8, 98, 2022)
err2024-06-06
err0
errOAAI
errRugo, Hope S.; Tolaney, Sara M.; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Hurvitz, Sara A.; O'Shaughnessy, Joyce; Cortes, Javier; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Piccart, Martine J.; Loibl, Sibylle; Goldenberg, David M.; Hong, Quan; Olivo, Martin; Itri, Loretta M.; Kalinsky, Kevin
errShare
errSave
Capivasertib and fulvestrant for patients with aromatase inhibitor-resistant HR positive/HER2-negative advanced breast cancer: exploratory analysis of PFS by AKT pathway gene from the Phase 3 CAPItello-291 trial
err2024-05-02
err1
PREAI
errHowell, Sacha; Rugo, Hope; Oliveira, Mafalda; Dalenc, Florence; Cortes, Javier; Gomez, Henry; Hu, Xichun; Jhaveri, Komal; Krivorotko, Petr; Loibl, Sibylle; Murillo, Serafin Morales; Okera, Meena; Park, Yeon; Sohn, Joo Hyuk; Toi, Masakazu; Tokunaga, Eriko; Zhukova, Lyudmila; Lloyd, Andrew; de Bruin, Elza; Egile, Coumaran; D'Cruz, Celina; Turner, Nicholas
errShare
errSave